Ticker
TELOCompany Name
TELOMIR PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 829.61K | $ 754.32K | 90.92% |
3/31/2025 | $ 491.19K | $ 403K | 82.05% |
12/31/2024 | $ 1.32M | $ 1.27M | 95.63% |
9/30/2024 | $ 1.04M | $ 834.64K | 80.1% |
6/30/2024 | $ 2.1M | $ 1.88M | 89.64% |
3/31/2024 | $ 3.5M | $ 3.27M | 93.47% |
12/31/2023 | $ 4.77M | $ 1.23K | 0.03% |
9/30/2023 | $ 5.32M | $ 2.45K | 0.05% |
12/31/2022 | $ 48.73K | $ 1.42K | 2.91% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for TELOMIR PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 1.42K ] / Assets [ $ 48.73K ]
(=) Cash to Assets [ 2.91% ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |